| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21.05. | XFRA 3FMA,833: AUSSETZUNG/SUSPENSION | 340 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILAEST.MED.INT.HLD.SP.ADR/3... ► Artikel lesen | |
| AESTHETIC MEDICAL INTERNATIONAL Aktie jetzt für 0€ handeln | |||||
| 23.04. | Aesthetic Medical International Holdings Group Ltd - 20-F, Annual and transition report of foreign private issuers | - | SEC Filings |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HIMS & HERS HEALTH | 27,280 | -0,15 % | Can Weight-Loss Momentum Lift Hims & Hers Stock Before Q2 Earnings? | ||
| BECTON DICKINSON | 151,55 | -0,92 % | ROUNDUP: Becton, Dickinson Boosts FY26 Adj. EPS Outlook | WASHINGTON (dpa-AFX) - While reporting financial results for the third quarter on Thursday, medical technology company Becton, Dickinson and Co. (BDX) raised its adjusted earnings guidance for... ► Artikel lesen | |
| RYMAN HEALTHCARE | 1,021 | +0,10 % | RYMAN HEALTHCARE LIMITED: Ryman Healthcare Limited - Capital Change Notice | ||
| WELLBEING DIGITAL SCIENCES | 0,007 | -100,00 % | KGK Science Receives Growth Investment Led By Maxim Partners | ||
| NIAGEN BIOSCIENCE | 2,760 | +2,22 % | Niagen Bioscience, Inc: Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168 | Collaboration will support pharmacokinetic, pharmacodynamic, and bioanalytical studies for Niagen Bioscience's lead investigational candidate for rare pediatric diseasesEvotec brings deep drug development... ► Artikel lesen | |
| SIENNA SENIOR LIVING | 14,100 | -1,40 % | Sienna Senior Living: Sienna Reports Second Quarter 2026 Financial Results and Forms Redevelopment Joint Venture with Fiera Infrastructure | MARKHAM, Ontario, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. ("Sienna" or the "Company") (TSX: SIA) today announced its financial results for the three and six months ended June 30... ► Artikel lesen | |
| MICROPORT SCIENTIFIC | 0,740 | -3,27 % | MICROPORT Subsidiary to Sell Over 44% Stake in Shanghai MicroPort Orthopedics, Receiving New Shares from TINAVI | ||
| EXTENDICARE | 20,200 | -4,72 % | Extendicare Inc.: Extendicare Announces 2026 Second Quarter Results | Markham, Ontario--(Newsfile Corp. - August 6, 2026) - Extendicare Inc. (TSX: EXE) ("Extendicare" or the "Company") today reported results for the three and six months ended June 30, 2026. Second... ► Artikel lesen | |
| VERADIGM | 7,350 | -100,00 % | Veradigm Inc. - 8-K, Current Report | ||
| NATIONAL HEALTHCARE CORPORATION | 187,00 | -1,58 % | National HealthCare Corp. Profit Climbs In Q2 | ||
| HANGZHOU TIGERMED CONSULTING | 4,440 | +9,36 % | Dividendenbekanntmachungen (18.06.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 3I GROUP PLC GB00B1YW4409 0,48 GBP 0,5547 EUR ACADEMY SPORTS AND OUTDOORS INC US00402L1070 0,15 USD 0,1303 EUR AEP PLANTATIONS... ► Artikel lesen | |
| UNIPHAR | 4,225 | -0,59 % | Uniphar PLC - Holding(s) in Company | ||
| IMMUNOVIA | 0,011 | -5,17 % | Immunovia AB: Immunovia Publishes Interim Report for April-June 2026 | Highlights April-June 2026Net sales and operating results for Q2 2026 in line with expectations: Net sales of 381 KSEK (90) for the period were comprised primarily of revenue from PancreaSure tests... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 62,43 | 0,00 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| FRESENIUS | 47,060 | +0,81 % | EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius hebt aufgrund der starken operativen Geschäftsentwicklung die Ergebnisprognose für das Geschäftsjahr 2026 an | EQS-Ad-hoc: Fresenius SE & Co. KGaA / Schlagwort(e): Prognose / Gesamtjahr
Fresenius SE & Co. KGaA: Fresenius hebt aufgrund der starken operativen Geschäftsentwicklung die Ergebnisprognose... ► Artikel lesen |